Syon Capital’s Mirum Pharmaceuticals MIRM Stock Holding History

Syon Capital’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,682	Closed	-$276K	–	632
2024 Q4	$276K	Buy	+6,682	New	+$278K	0.02%	421

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Syon Capital's MIRM Position: Q1 2025 in Review

Syon Capital sold out of Mirum Pharmaceuticals (MIRM) in Q1 2025, closing a stake of 6,682 shares — an estimated $276K sold.

Syon Capital first reported a position in MIRM in Q4 2024 and held it in 1 quarter. The position peaked at $276K in Q4 2024. 214 funds tracked by Wall St. Rank hold MIRM as of Q1 2025.

Syon Capital reported no remaining Mirum Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Syon Capital sold 6,682 Mirum Pharmaceuticals shares in Q1 2025, an estimated $276K.
Syon Capital first reported a position in Mirum Pharmaceuticals in Q4 2024 and held it in 1 quarter.
Syon Capital's Mirum Pharmaceuticals position peaked at $276K in Q4 2024.
214 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2025.

Based on Syon Capital's 13F filing for Q1 2025, filed 15 May 2025.